'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.

Pubmed ID: 10853976

Journal: AIDS (London, England)

Publication Date: May 26, 2000

MeSH Terms: Humans, Male, ADP-ribosyl Cyclase, Adult, Antigens, CD, Antigens, Differentiation, CD4 Lymphocyte Count, CD8-Positive T-Lymphocytes, Female, HIV Infections, HIV-1, Membrane Glycoproteins, Models, Biological, NAD+ Nucleosidase, RNA, Viral, Receptors, Tumor Necrosis Factor, Receptors, Tumor Necrosis Factor, Type II, Tumor Necrosis Factor-alpha, Virus Replication, ADP-ribosyl Cyclase 1

Grants: N01-HB-57115, N01-HB-57116, N01-HB-57117

Authors: Lederman MM, Kalish LA, Asmuth D, Fiebig E, Mileno M, Busch MP

Cite As: Lederman MM, Kalish LA, Asmuth D, Fiebig E, Mileno M, Busch MP. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses. AIDS 2000 May 26;14(8):951-8.

Studies:

Abstract

OBJECTIVE: To model the relationships among HIV-1 replication, immune activation and CD4+ T-cell losses in HIV-1 infection. METHODS: Cross-sectional analysis of baseline data from the Viral Activation by Transfusion Study. Comparisons of unadjusted and adjusted correlative analyses to establish models for mechanisms of cell loss in AIDS. RESULTS: Using these analyses, significant correlations were found among plasma levels of tumor necrosis factor alpha (TNFalpha) and its type two receptor (TNFrII), interleukin-6 (IL-6), beta2-microglobulin, expression of CD38 and HLA-DR on CD8+ T lymphocytes and plasma levels of HIV-1 RNA. When correlations among these indices were adjusted for possible intermediary correlations, the relationship between HIV-1 RNA levels and all plasma markers of immune activation could be accounted for by the correlation between plasma HIV-1 RNA and plasma TNFrII levels. In addition, the negative correlations that both HIV-1 RNA levels and TNFrII levels had with CD4+ T-cell counts were partially accounted for by the correlations of HIV-1 RNA and TNFrII with CD38 expression on CD8+ T cells. In persons with advanced disease (CD4+ T cells < 50 x 10(6)/l) IL-6 levels were inversely correlated with CD4+ T-cell counts. CONCLUSIONS: This analysis is consistent with a model wherein HIV-1 replication induces TNFalpha expression that induces multiple other indices of immune activation. In this model, HIV-1 replication and TNFalpha expression induce CD4+ T-cell losses at least in part through mechanisms reflected in heightened CD38 expression.